Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Traxion Sab De Cv Ord Shs GRPOF

Grupo Traxion SAB de CV is a Mexico-based company engaged in the transportation sector. The Company provides logistics services within eight business areas: Fright, including intermodal and multimodal services, door-to-door, national and cross-border distribution, among others; Integrated logistics, including logistics management, aerial and maritime services and custom transportation support... see more

PINL:GRPOF - Post Discussion

View:
Post by Karline on Mar 26, 2018 9:59pm

Theory

I’m not usually into conspiracy theories but after reading the article on Apotex today it made me wonder yet again if they could be the private distribution partner...the impending partnership announcement went secret right around the time of the tragic news, RIP.
However, considering the ambitions of Apotex I could see them being involved with Tetra’s smokable product while working on their own pill formulas to conquer the broader medicinal market. Pardon my ramblings Tetra longs, serious feedback welcome :)
Comment by LeafRider on Mar 26, 2018 11:24pm
This post has been removed in accordance with Community Policy
Comment by Karline on Mar 27, 2018 12:32am
Thanks for your response Leaf...it’s all speculation but after said article my slant was really a bit more negative, that they are full steam ahead in direct competition.. As for Triple, most of us read around here, including between the lines :) The sudden decision to hold off on the announcement, first for privacy, to stave off competition and now to integrate marketing, until AFTER ...more  
Comment by gkmackdadzzz1 on Mar 27, 2018 12:05pm
This post has been removed in accordance with Community Policy
Comment by LeafRider on Mar 27, 2018 12:18pm
This post has been removed in accordance with Community Policy
Comment by gkmackdadzzz1 on Mar 27, 2018 1:00pm
This post has been removed in accordance with Community Policy
Comment by stocktickler87 on Mar 27, 2018 1:12pm
You're trying too hard gkmackdadzzz1. No one cares. You spent all that time typing. Such a shame. Sad.
Comment by Knowbull1 on Mar 27, 2018 1:42pm
I've yet to hear of a treatment by big pharma that doesn't include risk to reward analogy. The more you look into pain/disease management, be it personal experience or not, the more you understand the risk/reward process and how this is a clinical/personal decision at the end of the day. Inhalation is a prompt delivery option that will appeal to MANY moving forward. Do appreciate the views ...more  
Comment by LeafRider on Mar 27, 2018 2:26pm
This post has been removed in accordance with Community Policy
Comment by Karline on Mar 27, 2018 4:58pm
No need for viciousness Gk, it was mere conjecture. Didn’t know ‘Joint Venture’, ‘Partnership’ and ‘Agreement’ dictated exclusivity for either company.  In any case, I withdraw my two cents since the CEO doesn’t seem to support ingestion by smoking.. Kara out! GLTA :)
Comment by Viceroy77 on Mar 27, 2018 12:49am
My guess is they're partnered with Purkinje.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities